MK

Mushabbar Khan

Active Director Director DIN 10331563
DIN 10331563 First appointment Sep 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mushabbar Khan

Data last updated:

Mushabbar Khan is a Director at Adwok Lifesciences Private Limited (since 2023). The company operates in Pharma.

DIN 10331563
Primary Designation Director
Industry Pharma
First Appointment 22 Sep 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adwok Lifesciences Private Limited U47721UP2023PTC189720
Director22 Sep 20232023Active

Board colleagues of Mushabbar Khan

NameDINCompanyDesignation
Manju Agarwal11496941Adwok Lifesciences Private LimitedAdditional Director
Swati Goyal10331562Adwok Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Adwok Lifesciences Private Limited
Premium access

Shareholding and investment profile for Mushabbar Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mushabbar Khan

Mushabbar Khan currently holds 1 directorship: Adwok Lifesciences Private Limited (Director, since 22 Sep 2023).

Mushabbar Khan was first appointed on 22 Sep 2023 as Director at Adwok Lifesciences Private Limited.

The current boards of Mushabbar Khan's companies include Manju Agarwal (Adwok Lifesciences Private Limited), Swati Goyal (Adwok Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available